Serial 18F-Fluorodeoxyglucose Positron Emission Tomography to Assess the Efficacy of Infliximab in Steroid Refractory Cardiac Sarcoidosis

Abstract

Graphical abstract (only): Legend: Graphical abstract summarizing the findings of this observational study, which through serial 18F-FDG-PET/CT imaging, supports the use of infliximab in the management of refractory cardiac sarcoidosis. CMA - cardiac metabolic activity, EF - ejection fraction, 18F-FDG-PET/CT - fluorodeoxyglucose-positron emission tomography/computed tomography, LV - left ventricular, MRI - magnetic resonance imaging, SUV - standardized uptake value.

Publication DOI: https://doi.org/10.1016/j.nuclcard.2025.102265
Divisions: College of Health & Life Sciences > Aston Medical School
College of Health & Life Sciences > Aston Medical School > Translational Medicine Research Group (TMRG)
College of Health & Life Sciences
Aston University (General)
Additional Information: Copyright © 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Publication ISSN: 1071-3581
Last Modified: 27 Jun 2025 07:13
Date Deposited: 26 Jun 2025 08:53
Full Text Link:
Related URLs: https://www.sci ... 071358125001394 (Publisher URL)
PURE Output Type: Article
Published Date: 2025-06-09
Published Online Date: 2025-06-09
Accepted Date: 2025-05-17
Authors: Crowley, Louise E.
Jenkins, Ellen
Ranasinghe, Akalanka
Naneishvili, Tamara
Yuan, Mengshi
Hussain, Khalid
Leyva-Leon, Francisco
Crawshaw, Anjali
Moody, William E.

Download

[img]

Version: Accepted Version

License: Creative Commons Attribution


Export / Share Citation


Statistics

Additional statistics for this record